One test. 98 genes. 25 Hereditary Cancers.
Broadest gene panel, more hereditary cancers
The test surveys for increased genetic risk of 25 cancers including some of the most common cancers: Lung, Breast, Colorectal, Prostate, Oral, along with Stomach, Bladder, Pancreas, Kidney, Thyroid, Ovary and others.
As an example of the extensive breadth of the gene panel analyzed by CellMax Life, to assess breast cancer risk, the CellMax-DNA test not only covers BRCA1 and BRCA2 genes entirely, but also examines a number of other genes associated with breast cancer including ATM, BARD1, CDH1, CHEK2, NBN, NF1, PALB2, PPM1D, PTEN, RAD51C, RAD51D, STK11, TP53.